Alexis Talbot

24PUBLICATIONS
165CO-AUTHORS
Molecular targetsMedical mycologyMicro- and nanosystemsGene and molecular therapySimulation, modelling, and programming of mechatronics systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Oct 15, 2026
Disruption of the CRL5 ubiquitin ligase complex enhances engineered T-cell persistence under chronic tumor antigen exposure.

|Feb 25, 2026
Patient-Centered Education Through A Massive Open Online Course (MOOC) for Patients With Multiple Myeloma and Caregivers: Descriptive Study of Knowledge Gains by French Association of Patients With Multiple Myeloma (AF3M) and French-Speaking Myeloma Intergroup (IFM).

Alexis Talbot, Bernard Delcour, Laurent Gillot

|Nov 24, 2025
Site-specific genome engineering of primary human natural killer cells for programmable anti-tumor function.

Vincent Allain, Allison G Rothrock, Pierre-Louis Bernard

|Oct 24, 2025
35 years of academic trials focusing on high-dose therapy and autologous stem cell transplantation: the Intergroupe Francophone du Myélome (IFM) experience.

Philippe Moreau, Cyrille Hulin, Alexis Talbot

|Oct 21, 2025
Integrated epigenetic and genetic programming of primary human T cells.

Laine Goudy, Alvin Ha, Ashir A Borah

|Sep 18, 2025
Poor outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French study.

Sarah Cayla, Lionel Karlin, Jérôme Lambert

Pageof 4

Frequent Collaborators

7 joint publications

Justin Eyquem

5 joint publications

Jill Corre

5 joint publications

Aurore Perrot

5 joint publications

Alexander Marson